A Toxicological Evaluation of Methylliberine (Dynamine®)

Methylliberine (CAS 51168-26-4), a methoxiuric acid, is a caffeine metabolite present at low levels in various Coffea plants; however, very little has been published regarding this compound and we could find no toxicological data in the public domain. Therefore, we undertook the toxicological invest...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy S. Murbach, Róbert Glávits, John R. Endres, Amy E. Clewell, Gábor Hirka, Adél Vértesi, Erzsébet Béres, Ilona Pasics Szakonyiné
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2019/4981420
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554779599962112
author Timothy S. Murbach
Róbert Glávits
John R. Endres
Amy E. Clewell
Gábor Hirka
Adél Vértesi
Erzsébet Béres
Ilona Pasics Szakonyiné
author_facet Timothy S. Murbach
Róbert Glávits
John R. Endres
Amy E. Clewell
Gábor Hirka
Adél Vértesi
Erzsébet Béres
Ilona Pasics Szakonyiné
author_sort Timothy S. Murbach
collection DOAJ
description Methylliberine (CAS 51168-26-4), a methoxiuric acid, is a caffeine metabolite present at low levels in various Coffea plants; however, very little has been published regarding this compound and we could find no toxicological data in the public domain. Therefore, we undertook the toxicological investigation of a pure, synthetic form of methylliberine in order to evaluate its potential health hazards as a food ingredient. A (1) bacterial reverse mutation test, (2) in vitro mammalian chromosomal aberration test, (3) in vivo mammalian micronucleus test, and (4) 90-day repeated-dose oral toxicity study in rats with a 28-day recovery period were conducted. No in vitro mutagenic or clastogenic activity was observed in the presence or absence of metabolic activation up to the maximum OECD recommended test concentrations. No genotoxicity was observed in the mammalian micronucleus study up to the highest dose tested of 700 mg/kg bw. In the 90-day study, methylliberine was administered to Han:WIST rats at doses of 0, 75, 112, 150, 187, and 225 mg/kg bw/day. No mortality or morbidity was observed and no toxicologically relevant clinical effects or effects on clinical pathology parameters were observed. In male animals, test item-related effects on body weight and sexual organs, which were not reversible after a 28-day recovery period without treatment, were observed in the high-dose group. Body weight development was also slightly and reversibly depressed in the 187 mg/kg bw/day male group. No toxicological effects were observed in females. The NOAEL for females was determined to be 225 mg/kg bw/day, the highest dose tested, while the NOAEL for males was determined to be 150 mg/kg bw/day. Future studies are encouraged to corroborate the safety, and assess efficacy, of methylliberine in humans.
format Article
id doaj-art-530b6916a8ca499896f39a25874713e5
institution Kabale University
issn 1687-8191
1687-8205
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-530b6916a8ca499896f39a25874713e52025-02-03T05:50:34ZengWileyJournal of Toxicology1687-81911687-82052019-01-01201910.1155/2019/49814204981420A Toxicological Evaluation of Methylliberine (Dynamine®)Timothy S. Murbach0Róbert Glávits1John R. Endres2Amy E. Clewell3Gábor Hirka4Adél Vértesi5Erzsébet Béres6Ilona Pasics Szakonyiné7AIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USAToxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122 Budapest, HungaryAIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USAAIBMR Life Sciences, Inc., 2800 East Madison Street, Suite 202, Seattle, WA 98112, USAToxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122 Budapest, HungaryToxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122 Budapest, HungaryToxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122 Budapest, HungaryToxi-Coop Zrt., Magyar Jakobinusok tere 4/B, H-1122 Budapest, HungaryMethylliberine (CAS 51168-26-4), a methoxiuric acid, is a caffeine metabolite present at low levels in various Coffea plants; however, very little has been published regarding this compound and we could find no toxicological data in the public domain. Therefore, we undertook the toxicological investigation of a pure, synthetic form of methylliberine in order to evaluate its potential health hazards as a food ingredient. A (1) bacterial reverse mutation test, (2) in vitro mammalian chromosomal aberration test, (3) in vivo mammalian micronucleus test, and (4) 90-day repeated-dose oral toxicity study in rats with a 28-day recovery period were conducted. No in vitro mutagenic or clastogenic activity was observed in the presence or absence of metabolic activation up to the maximum OECD recommended test concentrations. No genotoxicity was observed in the mammalian micronucleus study up to the highest dose tested of 700 mg/kg bw. In the 90-day study, methylliberine was administered to Han:WIST rats at doses of 0, 75, 112, 150, 187, and 225 mg/kg bw/day. No mortality or morbidity was observed and no toxicologically relevant clinical effects or effects on clinical pathology parameters were observed. In male animals, test item-related effects on body weight and sexual organs, which were not reversible after a 28-day recovery period without treatment, were observed in the high-dose group. Body weight development was also slightly and reversibly depressed in the 187 mg/kg bw/day male group. No toxicological effects were observed in females. The NOAEL for females was determined to be 225 mg/kg bw/day, the highest dose tested, while the NOAEL for males was determined to be 150 mg/kg bw/day. Future studies are encouraged to corroborate the safety, and assess efficacy, of methylliberine in humans.http://dx.doi.org/10.1155/2019/4981420
spellingShingle Timothy S. Murbach
Róbert Glávits
John R. Endres
Amy E. Clewell
Gábor Hirka
Adél Vértesi
Erzsébet Béres
Ilona Pasics Szakonyiné
A Toxicological Evaluation of Methylliberine (Dynamine®)
Journal of Toxicology
title A Toxicological Evaluation of Methylliberine (Dynamine®)
title_full A Toxicological Evaluation of Methylliberine (Dynamine®)
title_fullStr A Toxicological Evaluation of Methylliberine (Dynamine®)
title_full_unstemmed A Toxicological Evaluation of Methylliberine (Dynamine®)
title_short A Toxicological Evaluation of Methylliberine (Dynamine®)
title_sort toxicological evaluation of methylliberine dynamine r
url http://dx.doi.org/10.1155/2019/4981420
work_keys_str_mv AT timothysmurbach atoxicologicalevaluationofmethylliberinedynamine
AT robertglavits atoxicologicalevaluationofmethylliberinedynamine
AT johnrendres atoxicologicalevaluationofmethylliberinedynamine
AT amyeclewell atoxicologicalevaluationofmethylliberinedynamine
AT gaborhirka atoxicologicalevaluationofmethylliberinedynamine
AT adelvertesi atoxicologicalevaluationofmethylliberinedynamine
AT erzsebetberes atoxicologicalevaluationofmethylliberinedynamine
AT ilonapasicsszakonyine atoxicologicalevaluationofmethylliberinedynamine
AT timothysmurbach toxicologicalevaluationofmethylliberinedynamine
AT robertglavits toxicologicalevaluationofmethylliberinedynamine
AT johnrendres toxicologicalevaluationofmethylliberinedynamine
AT amyeclewell toxicologicalevaluationofmethylliberinedynamine
AT gaborhirka toxicologicalevaluationofmethylliberinedynamine
AT adelvertesi toxicologicalevaluationofmethylliberinedynamine
AT erzsebetberes toxicologicalevaluationofmethylliberinedynamine
AT ilonapasicsszakonyine toxicologicalevaluationofmethylliberinedynamine